Page last updated: 2024-11-01

n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide and Benign Neoplasms, Brain

n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide has been researched along with Benign Neoplasms, Brain in 6 studies

N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide: structure given in first source
NS-398 : A C-nitro compound that is N-methylsulfonyl-4-nitroaniline bearing an additional cyclohexyloxy substituent at position 2.

Research Excerpts

ExcerptRelevanceReference
"Notably, co-treatment of C6 glioma cells with 400 µmol/l NaHS and AOAA (an inhibitor of CBS) largely suppressed the above NaHS-induced effects."5.42Exogenous hydrogen sulfide promotes C6 glioma cell growth through activation of the p38 MAPK/ERK1/2-COX-2 pathways. ( Chen, J; Feng, J; Guo, R; He, J; Liu, C; Lu, Y; Zhang, W; Zhang, Y; Zhen, Y, 2015)
"Notably, co-treatment of C6 glioma cells with 400 µmol/l NaHS and AOAA (an inhibitor of CBS) largely suppressed the above NaHS-induced effects."1.42Exogenous hydrogen sulfide promotes C6 glioma cell growth through activation of the p38 MAPK/ERK1/2-COX-2 pathways. ( Chen, J; Feng, J; Guo, R; He, J; Liu, C; Lu, Y; Zhang, W; Zhang, Y; Zhen, Y, 2015)

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (66.67)29.6817
2010's1 (16.67)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Lombardi, F1
Augello, FR1
Artone, S1
Gugu, MK1
Cifone, MG1
Cinque, B1
Palumbo, P1
Zhen, Y1
Zhang, W1
Liu, C1
He, J1
Lu, Y1
Guo, R1
Feng, J1
Zhang, Y1
Chen, J1
Matsuo, M1
Yoshida, N1
Zaitsu, M1
Ishii, K1
Hamasaki, Y1
Obara, S1
Nakata, M1
Takeshima, H1
Katagiri, H1
Asano, T1
Oka, Y1
Maruyama, I1
Kuratsu, J1
Denkins, Y1
Kempf, D1
Ferniz, M1
Nileshwar, S1
Marchetti, D1
Joki, T1
Heese, O1
Nikas, DC1
Bello, L1
Zhang, J1
Kraeft, SK1
Seyfried, NT1
Abe, T1
Chen, LB1
Carroll, RS1
Black, PM1

Other Studies

6 other studies available for n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide and Benign Neoplasms, Brain

ArticleYear
Up-Regulation of Cyclooxygenase-2 (COX-2) Expression by Temozolomide (TMZ) in Human Glioblastoma (GBM) Cell Lines.
    International journal of molecular sciences, 2022, Jan-28, Volume: 23, Issue:3

    Topics: Antineoplastic Agents, Alkylating; beta Catenin; Brain Neoplasms; Cell Line, Tumor; Cell Proliferati

2022
Exogenous hydrogen sulfide promotes C6 glioma cell growth through activation of the p38 MAPK/ERK1/2-COX-2 pathways.
    Oncology reports, 2015, Volume: 34, Issue:5

    Topics: Animals; Brain Neoplasms; Carcinogenesis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cyclo

2015
Inhibition of human glioma cell growth by a PHS-2 inhibitor, NS398, and a prostaglandin E receptor subtype EP1-selective antagonist, SC51089.
    Journal of neuro-oncology, 2004, Volume: 66, Issue:3

    Topics: Animals; Brain Neoplasms; Cell Division; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygena

2004
Integrin-linked kinase (ILK) regulation of the cell viability in PTEN mutant glioblastoma and in vitro inhibition by the specific COX-2 inhibitor NS-398.
    Cancer letters, 2004, May-10, Volume: 208, Issue:1

    Topics: Brain; Brain Neoplasms; Cell Survival; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase

2004
Role of omega-3 polyunsaturated fatty acids on cyclooxygenase-2 metabolism in brain-metastatic melanoma.
    Journal of lipid research, 2005, Volume: 46, Issue:6

    Topics: Animals; Brain; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Collagen; Cyclooxygenase 2; D

2005
Expression of cyclooxygenase 2 (COX-2) in human glioma and in vitro inhibition by a specific COX-2 inhibitor, NS-398.
    Cancer research, 2000, Sep-01, Volume: 60, Issue:17

    Topics: Adult; Animals; Apoptosis; Astrocytoma; Brain; Brain Neoplasms; Cell Division; Cell Movement; Cocult

2000